6/7/2007

Amgen says it has agreed to buy Alantos Pharmaceuticals for $300 million, gaining access to drugs for treating diabetes and inflammatory diseases. The acquisition is part of a buying spree by Amgen, which just announced a similar purchase of Ilypsa.

Full Story:
Red Herring

Related Summaries